01102nam a2200229 a 450000100080000000500110000800800410001910000180006024501950007826001430027330000120041652002830042865000160071165000140072765000110074170000180075270000190077070000240078970000170081370000200083070000220085019416212012-12-07       2012    bl uuuu     u00u1 u    #d1 aGASPAR, E. B.  aDevelopment of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.h[electronic resource]  aIn: SIMPÓSIO EMBRAPA LABEX EUA DE SANIDADE ANIMAL, 2., 2012, Brasília, DF. Anais... Brasília, DF: Embrapa Estudos e Capacitaçãoc2012  ap. 153.  aThis project aims the development of a new vaccine against babesiosis and anaplasmosis based on a chimeric protein and new adjuvants. A chimeric protein formed by Anaplasma marginale VirB9 and Virb10 protein and B. bigemina PO protein will be constructed by genetic engineering.  aAnaplasmose  aBabesiose  aVacina1 aSANTOS, L. R.1 aARAÚJO, F. R.1 aGULIAS-GOMES, C. C.1 aLINCOPAN, N.1 aBRANDÃO, H. M.1 aROSINHA, G. M. S.